![Shmuel Ben Zvi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Shmuel Ben Zvi
Director/Board Member at PROTALIX BIOTHERAPEUTICS, INC.
Net worth: - $ as of 2024-11-29
Profile
Shmuel Ben Zvi is an Independent Director at Protalix Biotherapeutics, Inc. and the Manager & Owner of Shmuel (Muli) Ben Zvi Ltd.
He previously served as the Deputy CEO, VP-Finance & Strategy at Teva Pharmaceutical Industries Ltd.
from 2004 to 2014.
He was also the Chairman of Bank Leumi Le-Israel B.M.
from 2023 to 2024 and an Independent Non-Executive Director at Vascular Biogenics Ltd.
from 2018 to 2023.
Additionally, he held the position of Head-Budget Department at Israel Ministry of Defense from 2000 to 2004.
Dr. Ben Zvi has an educational background from Tel-Aviv University, where he obtained undergraduate, graduate, and doctorate degrees.
His current job(s) include being an Independent Director at Protalix Biotherapeutics, Inc. and the Manager & Owner of Shmuel (Muli) Ben Zvi Ltd.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-09-28 | 0 ( -.--% ) | - $ | 2024-11-29 |
Latest news about Shmuel Ben Zvi
Shmuel Ben Zvi active positions
| Companies | Position | Start |
|---|---|---|
| PROTALIX BIOTHERAPEUTICS, INC. | Director/Board Member | 2022-06-29 |
| Shmuel (Muli) Ben Zvi Ltd. | Corporate Officer/Principal | - |
Former positions of Shmuel Ben Zvi
| Companies | Position | End |
|---|---|---|
| BANK LEUMI LE-ISRAEL B.M. | Chairman | 2024-11-27 |
| NOTABLE LABS, LTD. | Director/Board Member | 2023-10-15 |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | 2014-11-30 |
| Israel Ministry of Defense | Corporate Officer/Principal | 2003-12-31 |
| SOL-GEL TECHNOLOGIES LTD. | Director/Board Member | - |
Training of Shmuel Ben Zvi
| Tel-Aviv University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| BANK LEUMI LE-ISRAEL B.M. | Finance |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
| SOL-GEL TECHNOLOGIES LTD. | Health Technology |
| PROTALIX BIOTHERAPEUTICS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
| Shmuel (Muli) Ben Zvi Ltd. | |
Vascular Biogenics Ltd.
 Vascular Biogenics Ltd. BiotechnologyHealth Technology Vascular Biogenics Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of next-generation, targeted medicines for difficult-to-treat medical conditions. Its product candidates are built off of its platform technologies: Vascular Targeting System (VTS), a gene-based technology targeting newly formed blood vessels and Monocyte Targeting Technology (MTT), an antibody-based technology able to specifically inhibit monocyte migration for immune-inflammatory applications. The company was founded by Dror Harats and Jacob George on January 27, 2000 and is headquartered in Modi'in, Israel. | Health Technology |
| Israel Ministry of Defense | Government |
- Stock Market
- Insiders
- Shmuel Ben Zvi